Berlin - Delayed Quote EUR

INmune Bio Inc (0Y2.BE)

6.20
-0.15
(-2.36%)
At close: May 9 at 9:52:06 PM GMT+2
Loading Chart for 0Y2.BE
  • Previous Close 6.35
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 10.20
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 0Y2.BE

View More

Performance Overview: 0Y2.BE

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

0Y2.BE
35.37%
S&P 500 (^GSPC)
3.77%

1-Year Return

0Y2.BE
38.61%
S&P 500 (^GSPC)
8.55%

3-Year Return

0Y2.BE
5.34%
S&P 500 (^GSPC)
41.81%

5-Year Return

0Y2.BE
40.38%
S&P 500 (^GSPC)
93.18%

Compare To: 0Y2.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0Y2.BE

View More

Valuation Measures

As of 5/9/2025
  • Market Cap

    142.77M

  • Enterprise Value

    124.46M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.91k

  • Price/Book (mrq)

    4.98

  • Enterprise Value/Revenue

    9.98k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0Y2.BE

View More